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34 patients (55%).no patient died during the hospitalization, complications
(mainly arrhythmias) occurred in 19.6% of cases.
Conclusion: ACS in the young have specific epidemiological characteris-
tics. Cannabis users represent 22.9% of this population.
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Aims: Gender differences in management of patients with acute coronary
syndromes (ACS) have been reported. The aim of this study was to evaluate
the impact of gender on myocardial revascularization in patients with ACS
from a French nationwide registry (ONACI). 
Methods and Results: We analysed data from a nationwide French pro-
spective multicentre registry including 64,932 ACS patients (mean age
65.7±13.3; 27% women, 31% ST-elevation myocardial infarction (STEMI))
recruited in 99 centres between 2004 and 2008. Women were older than men
and had higher rates of cardiovascular risk factors. Women were more likely
to have normal vessel/non-significant coronary artery disease (<50% stenosis
in all epicardial vessels; 8.4% vs. 3.8%, p<0.001) and less likely to have left-
main and three vessel disease. After adjustment for age, risk factor, and extent
of disease, myocardial revascularization (defined as the use of percutaneous
coronary intervention (PCI) or coronary artery bypass grafting) was less fre-
quently used in women than in men (adjusted OR=0.83; 95% CI: 0.78-0.87).
For those receiving PCI, In-hospital mortality occurring within 24 hours of
intervention was higher in women (3.6% vs. 1.2%; adjusted OR=0.51; 95%
IC: 1.22-1.87).
Conclusion: In the present study, women with ACS were likely to have
cardiovascular disease risk factors, but were more likely to have normal
vessel/non-significant angiographic coronary artery disease. In patients with
advanced disease, myocardial revascularization seems to be less used in
women compared to men whatever the type of ACS. Further study regarding
long-term clinical outcomes according to sex and myocardial revascularization
is warranted.
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Aim: The real clinical impact of Optical Coherence Tomography (OCT) –
defined abnormalities remains unknown. We investigated prognostic impact of
tissue protrusion between stent struts after stent implantation in patients with
non-ST elevation acute coronary syndromes (NSTEACS).
Methods: Prospective study of consecutive NSTEACS pts (≤72 h) under-
going PCI for an infarct-related artery presenting a single lesion without dif-
fuse disease on the culprit artery. Pts were treated at the operator’s discretion.
OCT was performed after initial coronary angiogram and at end of angioplasty
procedure. Prolapse was defined as projection of tissue (plaque/thrombus) into
the lumen between stent struts after implantation. Primary endpoint of proce-
dural complications associated no reflow + PCI-related myocardial infarction
(MI) (20% rise in troponin over baseline at 24h). Secondary endpoint was
functional result of angioplasty assessed by fractional flow reserve (FFR)
measured at end of procedure. 
Results: 43 pts were included, mean age 63±11 ans, 90% men. Tissue pro-
trusion was observed in 35(81%), tissue took up a median 8.85% [IQR 6.2-
14.2%] of intra-luminal area over a median length of 2.8mm [IQR 1.4-5.2].
Presence of protrusion was not associated with cardiovascular risk factors or
pre-treatment with aspirin, thienopyridines, antiGP IIb/IIIa or anticoagulants.
Tissue protrusion had no impact on procedural complications or FFR (Table). 
Conclusion: Tissue protrusion through struts after stent implantation is fre-
quent on OCT in NSTEACS pts undergoing angioplasty. It occludes on
average 10% of in-stent area but does not limit flow or impact on post-proce-
dural complications.
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Background: Silent Atrial Fibrillation (AF) has recently been shown to be
common in acute myocardial infarction (AMI) and to dramatically increase in-
hospital death. However, the long term prognosis of silent AF in AMI remains
unknown. 
Methods: From the 1st May 2011 and the 31st January 2013 all the
consecutive patients were prospectively analyzed by continuous ECG moni-
toring (CEM) during the first 48 hours after admission for an AMI. Silent AF
was defined as asymptomatic episodes lasting at least 30 sec. Patients dis-
charged alive and with a follow-up at 1 year were included in the present
study. Patients who developed silent AF were compared with symptomatic AF
and No AF group.
Results: Among the 737 patients included, 96 (13.0%) developed silent AF
and 56 (7.6%) developed symptomatic AF during their hospital stay.
Compared with the no AF group, patients with silent AF were markedly older
80 (64-84) vs. 61 (53-75) years; p<0.001), more frequently women (42% vs.
30%); p=0.069), and less frequently smoker (24% vs. 37%; p<0.001).GRACE
risk score was significantly higher in silent AF group (131(101-148)) than in
no AF group (98(75-); p<0.001). They also had a significant left atrial (LA)
enlargement with LA surface indexed at 10.1 (8.5-12.6) vs. 9.2 (7.4-10.9)cm²/
m²; p<0.001 and LA volume indexed 29.4 (21.0-43.1) vs. 24.1 (18.1-32.9)
cm3/m²; p<0.001. At one year follow-up, rehospitalizations for heart failure
were more frequent after silent AF (4.2%) or symptomatic AF (8.9%) than in
no AF group (1.4%), (p<0.001). One year mortality was dramatically higher
in silent AF group (9.4%) and in symptomatic AF group (17.9%) than in no
AF group (3.8%) (p<0.001). 
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Abstract 0441 – Table
1st quartile 
[0-6.2%] 
2nd quartile 
[6.21-8.85%] 
3rd quartile 
[8.86-14.15%] 
4th quartile 
[14.16-31%] 
1st quartile 
[0-6.2%] 
No reflow 7.7% 22.2% 0 25% 0.33
Peri-procedural MI 6 (46%) 8 (80%) 6 (60%) 5 (50%) 0.39
FFR post-stenting 0.94±0.03 0.94±0.06 0.93±0.03 0.93±0.04 0.99
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